Cédric Gubelmann

Cédric Gubelmann

Auto-generated profile, based on publicly available information

Cédric Gubelmann

Department of Medicine, Internal Medicine, Lausanne University Hospital (CHUV) and University of Lausanne, Lausanne, Switzerland

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 November 2014 in PLOS ONE
Verified
Journal Article
Open access
PDF file
HMHelena Marti-Soler
Helena Marti-Soler
SGSemira Gonseth
Semira Gonseth
CGCédric Gubelmann
Cédric Gubelmann
SSSilvia Stringhini
Silvia Stringhini
Pascal BovetPascal Bovet
Pascal Bovet
Pedro Marques-VidalPedro Marques-Vidal
Pedro Marques-Vidal
Cardiovascular diseases (CVD) mortality has been shown to follow a seasonal pattern. Several studies suggested several possible determinants of this pattern, including misclassification of causes of deaths. We aimed at assessing seasonality in overall, CVD, cancer and non-CVD/non-cancer mortality using data from 19 countries from different latitudes. Monthly mortality data were compiled from 19 countries, amounting to over 54 million deaths. We calculated ratios of the observed to the expected numbers of deaths in the absence of a seasonal pattern. Seasonal variation (peak to nadir difference) for overall and cause-specific (CVD, cancer or non-CVD/non-cancer) mortality was analyzed using the cosinor function model. Mortality from overall, CVD and non-CVD/non-cancer showed a consistent seasonal pattern. In both hemispheres, the number of deaths was higher than expected in winter. In countries close to the Equator the seasonal pattern was considerably lower for mortality from any cause. For CVD mortality, the peak to nadir differences ranged from 0.185 to 0.466 in the Northern Hemisphere, from 0.087 to 0.108 near the Equator, and from 0.219 to 0.409 in the Southern Hemisphere. For cancer mortality, the seasonal variation was nonexistent in most countries. In countries with seasonal variation, mortality from overall, CVD and non-CVD/non-cancer show a seasonal pattern with mortality being higher in winter than in summer. Conversely, cancer mortality shows no substantial seasonality.

30 May 2014 in Heart
Verified
Journal Article
Open access
PDF file
HMHelena Marti-Soler
Helena Marti-Soler
CGCédric Gubelmann
Cédric Gubelmann
SAStefanie Aeschbacher
Stefanie Aeschbacher
LALuis Alves
Luis Alves
MBMartin Bobak
Martin Bobak
Pedro Marques-VidalPedro Marques-Vidal
Pedro Marques-Vidal
Objective: To assess the seasonality of cardiovascular risk factors (CVRF) in a large set of population-based studies. Methods: Cross-sectional data from 24 population-based studies from 15 countries, with a total sample size of 237 979 subjects. CVRFs included Body Mass Index (BMI) and waist circumference; systolic (SBP) and diastolic (DBP) blood pressure; total, high (HDL) and low (LDL) density lipoprotein cholesterol; triglycerides and glucose levels. Within each study, all data were adjusted for age, gender and current smoking. For blood pressure, lipids and glucose levels, further adjustments on BMI and drug treatment were performed. Results: In the Northern and Southern Hemispheres, CVRFs levels tended to be higher in winter and lower in summer months. These patterns were observed for most studies. In the Northern Hemisphere, the estimated seasonal variations were 0.26 kg/m2 for BMI, 0.6 cm for waist circumference, 2.9 mm Hg for SBP, 1.4 mm Hg for DBP, 0.02 mmol/L for triglycerides, 0.10 mmol/L for total cholesterol, 0.01 mmol/L for HDL cholesterol, 0.11 mmol/L for LDL cholesterol, and 0.07 mmol/L for glycaemia. Similar results were obtained when the analysis was restricted to studies collecting fasting blood samples. Similar seasonal variations were found for most CVRFs in the Southern Hemisphere, with the exception of waist circumference, HDL, and LDL cholesterol. Conclusions: CVRFs show a seasonal pattern characterised by higher levels in winter, and lower levels in summer. This pattern could contribute to the seasonality of CV mortality.

30 March 2018 in SLEEP
Verified
Journal Article
Closed access
PDF file
CGCédric Gubelmann
Cédric Gubelmann
RHRaphael Heinzer
Raphael Heinzer
JHJosé Haba-Rubio
José Haba-Rubio
PVPeter Vollenweider
Peter Vollenweider
Pedro Marques-VidalPedro Marques-Vidal
Pedro Marques-Vidal
To evaluate the association of objective physical activity (PA) and sedentary behavior (SB) with sleep duration and quality. Cross-sectional study including 2649 adults (53.5% women, 45–86 years) from the general population. Proportions of time spent in PA and SB were measured using 14 day accelerometry. Low PA and high SB statuses were defined as the lowest and highest tertile of each behavior. “Inactive,” “Weekend warrior,” and “Regularly active” weekly patterns were also defined. Sleep parameters were derived from the accelerometer and validated questionnaires. High PA, relative to low PA, was associated with higher sleep efficiency (76.6 vs. 73.8%, p < 0.01) and lower likelihood of evening chronotype [relative-risk ratio (RR) and 95% CI: 0.71 (0.52; 0.97)]. Similar associations were found for low SB relative to high SB. “Weekend warriors” relative to “Inactives,” had higher sleep efficiency [76.4 vs. 73.9%, p < 0.01] and lower likelihood of evening chronotype [RR: 0.63 (0.43; 0.93)]. “Regularly actives,” relative to “Inactives,” had higher sleep efficiency [76.7 vs. 73.9%, p < 0.01] and tended to have less frequently an evening chronotype [RR: 0.75 (0.54; 1.04), p = 0.09]. No associations were found for PA and SB with sleep duration, daytime sleepiness, insomnia, and risk of sleep apnea (after adjustment for body mass index). High PA and low SB individuals, even if they do not sleep longer, have higher sleep efficiency and have less frequently an evening chronotype.

25 November 2016 in European Journal of Preventive Cardiology
Verified
Journal Article
Open access
CGCédric Gubelmann
Cédric Gubelmann
PVPeter Vollenweider
Peter Vollenweider
Pedro Marques-VidalPedro Marques-Vidal
Pedro Marques-Vidal
Subscription and open access journals from SAGE Publishing, the world's leading independent academic publisher.


1 June 2017 in International Journal of Cardiology
Verified
Journal Article
Closed access
CGCédric Gubelmann
Cédric Gubelmann
PVPeter Vollenweider
Peter Vollenweider
Pedro Marques-VidalPedro Marques-Vidal
Pedro Marques-Vidal